KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer

Conditions:   Gastric Cancer;   Esophagus Cancer
Intervention:   Drug: Oxaliplatin+Capecitabine+Pembrolizumab
Sponsors:   Duke University;   Merck Sharp & Dohme Corp.
Not yet recruiting

http://ift.tt/2AOXDGY